HVMN Sprint Was the Original Nootropic Pouch — Here's What Replaced It in 2026
Roon Team
HVMN Sprint Was the Original Nootropic Pill. Here's What Replaced It in 2026
HVMN Sprint was supposed to be the future of cognitive performance. A capsule-based nootropic stack from Nootrobox, the Silicon Valley startup that launched in 2014 with venture backing from Andreessen Horowitz and angel investors like Marissa Mayer. Sprint combined caffeine, L-theanine, and a few supporting compounds into a single pill designed for "immediate cognitive effect." The idea was right. The execution was first-generation.
Sprint is gone now. If you visit hvmn.com/products/sprint, you get redirected to a Ketone-IQ product page. The company rebranded entirely around exogenous ketones and officially became Ketone-IQ in 2024. But the premise Sprint was built on, portable cognitive performance with a smart ingredient stack, didn't die. It evolved.
Here's what that evolution looks like side by side.
HVMN Sprint vs. Modern Nootropic Pouches: Quick Comparison
| Feature | HVMN Sprint (Discontinued) | Roon | Nectr |
|---|---|---|---|
| Format | Capsule (2 per serving) | Sublingual pouch | Sublingual pouch |
| Caffeine | 200 mg | 80 mg | 50 mg |
| L-Theanine | 200 mg | 60 mg | Not listed |
| Other Key Actives | 400 mg Panax Ginseng | 25 mg Dynamine (methylliberine), 5 mg TeaCrine (theacrine) | Cognizin (citicoline), L-tyrosine |
| Anti-Tolerance Compound | None | Yes (theacrine) | None |
| Price/Serving | ~$0.84 (was $24.95/60 capsules) | ~$0.33-0.53/pouch | ~$0.47/pouch |
| Availability | Discontinued | takeroon.com | nectr.energy |
| Best For | N/A (no longer sold) | Sustained 6-8 hr focus, jitter-sensitive users | Citicoline fans, flavor variety |
The Rise and Fall of HVMN Sprint
Nootrobox was founded in 2014 by Stanford graduates Geoffrey Woo and Michael Brandt. Sprint was part of their original "Full Stack," a four-product nootropic system (Sprint, Rise, Kado-3, Yawn) designed to cover different aspects of cognitive and physical performance throughout the day.
Sprint's original formula contained caffeine, L-theanine, L-tyrosine, alpha-GPC, and huperzine A. The company later reformulated to a simpler stack: 200 mg caffeine, 200 mg L-theanine, and 400 mg Panax Ginseng. That reformulated version is what most reviewers tested and what appeared on Amazon listings.
Then came the CNBC story. In 2017, CNBC reported that HVMN's own commissioned clinical trial found Sprint was less effective than caffeine alone on several cognitive measures. The company disputed the framing, calling the tested product "CAF+," a non-commercial research variant. But the damage to public perception was real.
By 2021, HVMN had shifted its focus to Ketone-IQ, an exogenous ketone drink that launched publicly in January 2022. The nootropic line quietly disappeared. Sprint's product page now redirects to Ketone-IQ. The company rebranded as Ketone-IQ in 2024, completing the pivot.
What Sprint Got Right (and What It Missed)
Sprint's core insight was sound. Caffeine paired with L-theanine is one of the most well-studied nootropic combinations in the literature. A 2008 study published in Nutritional Neuroscience found that the L-theanine and caffeine combination improved both speed and accuracy on an attention-switching task at 60 minutes and reduced susceptibility to distracting information. A 2010 follow-up confirmed the pairing improves cognitive performance and increases subjective alertness.
Sprint built on a real foundation. But it had three design limitations:
1. No anti-tolerance mechanism. Caffeine tolerance is well-documented. Your body adapts, and the same dose produces diminishing returns over weeks. Sprint had nothing in its formula to address this.
2. Too much caffeine per serving. At 200 mg per dose, Sprint delivered the equivalent of two strong cups of coffee. That's fine for caffeine-naive users on day one, but it narrows the usable window. Take it after noon and you risk disrupting sleep. Stack it with morning coffee and you're pushing toward the 400 mg daily ceiling that the FDA considers generally safe.
3. Capsule format only. Oral capsules must survive stomach acid and first-pass liver metabolism before reaching the bloodstream. Sublingual delivery bypasses both. Research on sublingual pharmacokinetics shows this route reduces onset time and can improve bioavailability compared to conventional oral tablets, because the drug enters the bloodstream directly through the mucous membrane under the tongue.
The Compounds Sprint Didn't Have: Theacrine and Methylliberine
The biggest gap in Sprint's formula was the absence of two purine alkaloids that weren't widely available in consumer supplements during Sprint's era: theacrine (TeaCrine) and methylliberine (Dynamine).
Theacrine: The Anti-Tolerance Compound
Theacrine is structurally similar to caffeine but behaves differently in the body over time. A 2016 study in the Journal of the International Society of Sports Nutrition tested 60 healthy men and women taking either placebo, 200 mg, or 300 mg of TeaCrine daily for 8 weeks. The key finding: no evidence of tachyphylaxis (tolerance buildup) at either dose. The researchers noted there was "no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants."
This matters because caffeine's biggest long-term weakness is habituation. You need more to get the same effect. Theacrine, even at doses up to 300 mg/day for 8 consecutive weeks, showed no such pattern in this trial.
Methylliberine: The Fast-Onset Amplifier
Methylliberine (Dynamine) is another purine alkaloid with a shorter half-life than caffeine. It hits faster and clears faster, creating a "front-loaded" energy profile that complements caffeine's slower curve. A 2023 study published in Nutrients found that methylliberine supplementation improved multiple indices of affect (mood, motivation, energy perception) in 25 healthy adults in a double-blind crossover trial.
The Three-Compound Stack: What the Research Shows
The real story is what happens when you combine all three. A 2021 study published in Cureus tested 50 male e-gamers in a randomized crossover design, comparing caffeine alone (125 mg) against caffeine (125 mg) + Dynamine (75 mg) + TeaCrine (50 mg). The combination improved cognitive performance and reaction time without increasing self-reported anxiety or headaches.
A 2022 study in JISSN extended this to tactical personnel, finding that the caffeine-methylliberine-theacrine combination produced similar vigilance benefits to 300 mg of caffeine alone, but with more favorable hemodynamic responses (less blood pressure elevation). In other words: comparable cognitive output, lower cardiovascular cost.
Sprint had caffeine and L-theanine. It didn't have these two compounds, because the research supporting their use in consumer nootropics simply wasn't there yet in 2016.
Why the Format Shift Matters: Pouches vs. Pills
Sprint was a capsule. You swallowed two pills, waited 30-45 minutes for gastric absorption, and hoped your stomach contents didn't slow things down further. The nootropic pouch category that emerged after Sprint's discontinuation changes that equation.
Sublingual delivery, where active compounds absorb through the tissue under the tongue and inside the cheek, bypasses hepatic first-pass metabolism entirely. The compounds enter the bloodstream directly. Research on sublingual pharmacokinetics consistently shows faster onset compared to oral ingestion. One review noted that sublingual formulations can achieve faster onset of action and improved bioavailability versus swallowed tablets.
This is why the modern nootropic pouch category exists. It's the same basic idea Sprint pioneered (a pre-dosed cognitive performance stack you can take anywhere) delivered through a route that actually makes pharmacological sense for fast-acting compounds.
The Modern HVMN Sprint Alternatives
If you're searching for an HVMN Sprint alternative in 2026, the nootropic pouch category is where Sprint's original concept lives on. Here's how the main options compare:
| Product | Key Actives | Format | Approx. $/Serving | Best For |
|---|---|---|---|---|
| Roon | 80 mg caffeine, 60 mg L-theanine, 25 mg methylliberine, 5 mg theacrine | Sublingual pouch | ~$0.33-0.53 | Full-spectrum focus stack with anti-tolerance design |
| Nectr | 50 mg caffeine, Cognizin citicoline, L-tyrosine | Sublingual pouch | ~$0.47 | Citicoline-focused, wide flavor range |
| Fully Loaded Alpha | 50 mg caffeine, 50 mg Alpha-GPC, 50 mg L-tyrosine, 20 mg GABA | Sublingual pouch | ~$0.47 | Budget-friendly, proprietary blend |
| Ultra | 100 mg enfinity paraxanthine, alpha-GPC, L-theanine | Sublingual pouch | ~$1.50-2.00 | Caffeine-free stimulation via paraxanthine |
The nootropic pouch market has grown quickly since 2024, with prices landing between $5-8 per can across most brands. The differentiator isn't price. It's what's inside.
Frequently Asked Questions
When did HVMN Sprint launch?
Sprint launched as part of the Nootrobox product line, which debuted in 2014. The company rebranded from Nootrobox to HVMN in June 2017. Sprint went through at least one major reformulation during its lifespan, moving from a multi-ingredient stack (caffeine, L-theanine, L-tyrosine, alpha-GPC, huperzine A) to a simpler three-ingredient formula (200 mg caffeine, 200 mg L-theanine, 400 mg Panax Ginseng).
Why was HVMN Sprint discontinued?
HVMN never issued a formal discontinuation announcement. The company gradually shifted its focus to exogenous ketones, launching Ketone-IQ publicly in January 2022. The Sprint product page now redirects to Ketone-IQ. A 2017 clinical trial that found Sprint performed no better than caffeine alone on most cognitive measures likely accelerated the strategic pivot.
Can I still buy HVMN Sprint?
No. Sprint is no longer manufactured or sold by HVMN (now Ketone-IQ). Some expired stock may appear on third-party marketplaces, but the product is effectively dead. The company's entire product line now centers on Ketone-IQ exogenous ketone drinks and shots.
What is the best HVMN Sprint replacement?
The closest modern equivalent to Sprint's concept (a pre-dosed cognitive stack for on-demand focus) is a nootropic pouch. Roon contains the same caffeine + L-theanine base that Sprint was built on, plus methylliberine and theacrine for extended duration and tolerance resistance. The sublingual format also provides faster onset than Sprint's capsules.
Is Roon basically Sprint 2.0?
Not exactly. Roon and Sprint share a design philosophy (portable, pre-dosed cognitive performance), and both use the caffeine + L-theanine pairing as a foundation. But Roon's formula adds two compounds Sprint never had (methylliberine and theacrine), uses a lower caffeine dose (80 mg vs. 200 mg), and delivers through sublingual absorption instead of oral capsules. It's more of an evolution than a direct sequel.
Does theacrine really prevent tolerance?
An 8-week clinical trial with 60 subjects found no evidence of habituation at doses up to 300 mg/day of TeaCrine. The study measured energy, focus, concentration, and motivation at multiple time points and found no tachyphylactic response. That's a meaningful contrast to caffeine, where tolerance can develop within days of consistent use.
Are nootropic pouches better than capsules?
"Better" depends on what you're optimizing for. Sublingual pouches offer faster onset because they bypass stomach digestion and first-pass liver metabolism. Capsules offer more flexibility for high-dose or multi-ingredient formulas. For fast-acting cognitive compounds like caffeine and methylliberine, the sublingual route has clear pharmacokinetic advantages.
Related from Roon
- HVMN Discontinued Sprint and Pivoted to Ketones: 5 Modern Cognitive Performance Alternatives
- Performance Pouches for Productivity in 2026: 8 Brands Independently Ranked
- No-Crash Focus Supplements: The 2026 Buyer's Guide for Sustained Energy Without the Jitters
The Sprint Concept, Evolved
HVMN Sprint deserves credit. It was one of the first consumer products to package cognitive performance into a single, portable format backed by (at least attempted) clinical research. The idea that you could carry a dose of focus in your pocket and deploy it on demand was ahead of its time in 2014.
The science just wasn't there yet. Theacrine and methylliberine hadn't been studied in human combination trials. Sublingual delivery for nootropic compounds wasn't a consumer category. Sprint was working with the tools available, and those tools had limits.
Today, the concept Sprint pioneered lives in a different form. The same caffeine and L-theanine foundation Sprint relied on now appears in sublingual pouches that bypass stomach digestion entirely, paired with compounds like methylliberine and theacrine that simply did not exist in consumer nootropics during Sprint's era. The format is faster, the formulas are more complete, and the tolerance problem Sprint never addressed has a documented solution. Sprint was working with the tools available in 2014. The tools available in 2026 are meaningfully better.
Sprint's Formula, A Decade Later
Sprint's core bet was that a portable, pre-dosed cognitive stack could outperform a cup of coffee. That bet was right. What Sprint lacked was the compound research to back it up fully, a delivery format that matched the speed its users expected, and any mechanism to stay effective past the first few weeks of daily use.
Roon is built around exactly those gaps. The formula pairs caffeine and L-theanine (Sprint's foundation) with 25mg methylliberine for faster onset and 5mg theacrine for tolerance resistance, all delivered sublingually so the stack reaches your bloodstream without waiting on your stomach. At 80mg caffeine per pouch, it fits inside a full day without crowding out your morning coffee or your sleep window. Roon is not a substitute for sleep, nutrition, or deep work habits. It is a clean, zero-nicotine tool for the hours when sustained focus matters and a crash is not an option.
If Sprint's concept ever appealed to you, Roon is the version that exists now.
By Roon Team
